EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis

Fuzhen Zhang, Fan Zhang, Liang Li, Yu Pang

Journal of Infection and Public Health · 2024

DOI: 10.1016/j.jiph.2024.02.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Fuzhen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China; Department of Bacterio…. Hauptthemen laut MEDLINE: Artificial Intelligence, Tuberculosis, Pulmonary, Antitubercular Agents, Neural Networks, Computer. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional methods for monitoring pulmonary tuberculosis (PTB) treatment efficacy lack sensitivity, prompting the exploration of artificial intelligence (AI) to enhance monitoring. This review investigates the application of AI in monitoring anti-tuberculosis (ATTB) treatment, revealing its potential in predicting treatment duration, adverse reactions, outcomes, and drug resistance. It provides important insights into the potential of AI technology to enhance monitoring and management of ATTB treatment. Systematic search across six databases from 2013 to 2023 explored AI in forecasting PTB treatment efficacy. Support vector machine and convolutional neural network excel in treatment duration prediction, while random forest, artificial neural network, and classification and regression tree show promise in forecasting adverse reactions and outcomes. Neural networks and random forest are effective in predicting drug resistance. AI advancements offer improved monitoring strategies, better patient prognosis, and pave the way for future AI research in PTB treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceTuberculosis, PulmonaryAntitubercular AgentsNeural Networks, ComputerHumansTreatment OutcomeSupport Vector MachinePrognosis

Stichwörter der Autor:innen

Anti-tuberculosis treatmentArtificial intelligencePredictionPulmonary tuberculosisTherapeutic efficacy

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China; Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical Universit…
  • Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China.
  • Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing 101149, PR China. Electronic address: pangyupound@163.com.

Zitieren

APA

Zhang, F., Zhang, F., Li, L., & Pang, Y. (2024). Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.02.012

Vancouver

Zhang F, Zhang F, Li L, Pang Y. Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.02.012

BibTeX
@article{Zhang2024,
  author = {Zhang, Fuzhen and Zhang, Fan and Li, Liang and Pang, Yu},
  title = {Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis},
  journal = {Journal of Infection and Public Health},
  year = {2024},
  doi = {10.1016/j.jiph.2024.02.012}
}
Kostenlos starten →